CoChat

Neutralising effects of small molecule toxin inhibitors on nanofractionated coagulopathic Crotalinae snake venoms

Xie, Chunfang, Slagboom, Julien, Albulescu, Laura-Oana, Somsen, Govert W., Vonk, Freek J., Casewell, Nicholas R., Kool, Jeroen · 2020 · Acta Pharmaceutica Sinica B
Cited by 35

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.apsb.2020.09.005

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 58

  1. Gutiérrez, 2017, Snakebite envenoming, Nat Rev Dis Primers, 3, 1
  2. Williams, 2019, Strategy for a globally coordinated response to a priority neglected tropical disease: snakebite envenoming, PLoS Neglected Trop Dis, 13, 7059, 10.1371/journal.pntd.0007059 · DOI · Paper page
  3. Kasturiratne, 2008, The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths, PLoS Med, 5, e218, 10.1371/journal.pmed.0050218 · DOI · Paper page
  4. Chippaux, 2017, Snakebite envenomation turns again into a neglected tropical disease!, J Venom Anim Toxins incl Trop Dis, 23, 38, 10.1186/s40409-017-0127-6 · DOI · Paper page
  5. Maduwage, 2014, Current treatment for venom-induced consumption coagulopathy resulting from snakebite, PLoS Neglected Trop Dis, 8, 10.1371/journal.pntd.0003220 · DOI · Paper page
  6. Slagboom, 2017, Haemotoxic snake venoms: their functional activity, impact on snakebite victims and pharmaceutical promise, Br J Haematol, 177, 947, 10.1111/bjh.14591 · DOI · Paper page
  7. Ainsworth, 2018, The paraspecific neutralisation of snake venom induced coagulopathy by antivenoms, Commun Biol, 1, 34, 10.1038/s42003-018-0039-1 · DOI
  8. Cardoso, 2019, Multifunctional toxins in snake venoms and therapeutic implications: from pain to hemorrhage and necrosis, Front Ecol Evol, 7, 218, 10.3389/fevo.2019.00218 · DOI · Paper page
  9. de Silva, 2016, Adverse reactions to snake antivenom, and their prevention and treatment, Br J Clin Pharmacol, 81, 446, 10.1111/bcp.12739 · DOI · Paper page
  10. Morais, 2009, Snake antivenoms: adverse reactions and production technology, J Venom Anim Toxins Incl Trop Dis, 15, 2, 10.1590/S1678-91992009000100002 · doi:10.1590/s1678-91992009000100002
  11. Habib, 2013, Antivenom therapy of carpet viper (Echis ocellatus) envenoming: effectiveness and strategies for delivery in West Africa, Toxicon, 69, 82, 10.1016/j.toxicon.2013.01.002 · doi:10.1016/j.toxicon.2013.01.002
  12. Wang, 2018, Exploration of the inhibitory potential of varespladib for snakebite envenomation, Molecules, 23, 391, 10.3390/molecules23020391 · DOI · Paper page
  13. Bittenbinder, 2018, Coagulotoxic cobras: clinical implications of strong anticoagulant actions of African spitting Naja venoms that are not neutralised by antivenom but are by LY315920 (varespladib), Toxins, 10, 516, 10.3390/toxins10120516 · DOI · Paper page
  14. Bulfone, 2018, Developing small molecule therapeutics for the initial and adjunctive treatment of snakebite, J Trop Med, 2018, 4320175, 10.1155/2018/4320175 · DOI · Paper page
  15. Albulescu, 2020, Preclinical validation of a repurposed metal chelator as an early-intervention therapeutic for hemotoxic snakebite, Sci Transl Med, 12, 10.1126/scitranslmed.aay8314 · DOI · Paper page
  16. Layfield, 2020, Repurposing cancer drugs batimastat and marimastat to inhibit the activity of a group I metalloprotease from the venom of the Western diamondback rattlesnake, Crotalus atrox, Toxins, 12, 309, 10.3390/toxins12050309 · DOI · Paper page
  17. JMa, 2003, Skeletal muscle degeneration induced by venom phospholipases A2: insights into the mechanisms of local and systemic myotoxicity, Toxicon, 42, 915, 10.1016/j.toxicon.2003.11.005 · DOI · Paper page
  18. Serrano, 2005, Snake venom serine proteinases: sequence homology vs. substrate specificity, a paradox to be solved, Toxicon, 45, 1115, 10.1016/j.toxicon.2005.02.020 · DOI · Paper page
  19. Williams, 2019, Mechanisms underpinning the permanent muscle damage induced by snake venom metalloprotease, PLoS Neglected Trop Dis, 13, 10.1371/journal.pntd.0007041 · DOI
  20. Lewin, 2016, Varespladib (LY315920) appears to be a potent, broad-spectrum, inhibitor of snake venom phospholipase A2 and a possible pre-referral treatment for envenomation, Toxins, 8, 248, 10.3390/toxins8090248 · DOI · Paper page
  21. Abraham, 2003, Efficacy and safety of LY315920Na/S-5920, a selective inhibitor of 14-kDa group IIA secretory phospholipase A2, in patients with suspected sepsis and organ failure, Crit Care Med, 31, 718, 10.1097/01.CCM.0000053648.42884.89 · DOI
  22. Bryan-Quirós, 2019, Neutralizing properties of LY315920 toward snake venom group I and II myotoxic phospholipases A2, Toxicon, 157, 1, 10.1016/j.toxicon.2018.11.292 · DOI · Paper page
  23. King, 2003, Randomised double blind placebo control study of adjuvant treatment with the metalloproteinase inhibitor, marimastat in patients with inoperable colorectal hepatic metastases: significant survival advantage in patients with musculoskeletal side-effects, Anticancer Res, 23, 639
  24. Howes, 2007, Neutralization of the haemorrhagic activities of viperine snake venoms and venom metalloproteinases using synthetic peptide inhibitors and chelators, Toxicon, 49, 734, 10.1016/j.toxicon.2006.11.020 · DOI
  25. Shaposhnik, 2009, The synergistic inhibition of atherogenesis in apoE−/− mice between pravastatin and the sPLA2 inhibitor varespladib (A-002), J Lipid Res, 50, 623, 10.1194/jlr.M800361-JLR200 · DOI
  26. Rosenson, 2009, Effects of 1-H-indole-3-glyoxamide (A-002) on concentration of secretory phospholipase A2 (PLASMA study): a phase II double-blind, randomised, placebo-controlled trial, Lancet, 373, 649, 10.1016/S0140-6736(09)60403-7 · DOI
  27. Nicholls, 2014, Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial, JAMA, 311, 252, 10.1001/jama.2013.282836 · DOI · Paper page
  28. Gutierrez, 2007, Trends in snakebite envenomation therapy: scientific, technological and public health considerations, Curr Pharm Des, 13, 2935, 10.2174/138161207782023784 · DOI · Paper page
  29. Curran, 1999, Matrix metalloproteinases in tumour invasion and metastasis, J Pathol, 189, 300, 10.1002/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C · DOI · Paper page
  30. Rasmussen, 1997, Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat, Pharmacol Ther, 75, 69, 10.1016/S0163-7258(97)00023-5 · DOI · Paper page
  31. Underwood, 2003, The interaction of metal ions and marimastat with matrix metalloproteinase 9, J Inorg Biochem, 95, 165, 10.1016/S0162-0134(03)00100-4 · DOI
  32. Zhang, 1994, Structural interaction of natural and synthetic inhibitors with the venom metalloproteinase, atrolysin C (form d), Proc Natl Acad Sci, 91, 8447, 10.1073/pnas.91.18.8447 · DOI · Paper page
  33. Nagase, 1999, Matrix metalloproteinases, J Biol Chem, 274, 21491, 10.1074/jbc.274.31.21491 · DOI · Paper page
  34. Steward, 2000, Marimastat: the clinical development of a matrix metalloproteinase inhibitor, Expet Opin Invest Drugs, 9, 2913, 10.1517/13543784.9.12.2913 · DOI
  35. Albulescu, 2020, A combination of two small molecule toxin inhibitors provides pancontinental preclinical efficacy against viper snakebite, bioRxiv
  36. Takeda, 2012, Snake venom metalloproteinases: structure, function and relevance to the mammalian ADAM/ADAMTS family proteins, Biochim Biophys Acta Protein Proteonomics, 1824, 164, 10.1016/j.bbapap.2011.04.009 · DOI · Paper page
  37. Wax, 2013, Current use of chelation in American health care, J Med Toxicol, 9, 303, 10.1007/s13181-013-0347-2 · doi:10.1007/s13181-013-0347-2
  38. Lawson, 2016, Chelators in iron and copper toxicity, Curr Pharmacol Rep, 2, 271, 10.1007/s40495-016-0068-8 · DOI
  39. Urs, 2015, Inhibitory potential of three zinc chelating agents against the proteolytic, hemorrhagic, and myotoxic activities of Echis carinatus venom, Toxicon, 93, 68, 10.1016/j.toxicon.2014.11.224 · doi:10.1016/j.toxicon.2014.11.224
  40. Peters, 1945, British anti-lewisite (BAL), Nature, 156, 616, 10.1038/156616a0 · DOI · Paper page
  41. Verma, 2010, Accidental inorganic mercury chloride poisoning in a 2-year old child, Indian J Pediatr, 77, 1153, 10.1007/s12098-010-0143-9 · DOI
  42. Kathirgamanathan, 2013, Cardiac conduction block at multiple levels caused by arsenic trioxide therapy, Can J Cardiol, 29
  43. Ioannou, 2018, Interaction of British anti-lewisite (BAL) with copper (I) and copper (II) compounds in conjunction with Wilson's disease, Main Group Chem, 17, 1, 10.3233/MGC-180246 · doi:10.3233/mgc-180246
  44. Still, 2017, Multipurpose HTS coagulation analysis: assay development and assessment of coagulopathic snake venoms, Toxins, 9, 382, 10.3390/toxins9120382 · DOI
  45. Slagboom, 2020, High throughput screening and identification of coagulopathic snake venom proteins and peptides using nanofractionation and proteomics approaches, PLoS Neglected Trop Dis, 14, 10.1371/journal.pntd.0007802 · DOI
  46. Xie, 2020, Antivenom neutralization of coagulopathic snake venom toxins assessed by bioactivity profiling using nanofractionation analytics, Toxins, 12, 53, 10.3390/toxins12010053 · DOI
  47. Otero-Patiño, 2009, Epidemiological, clinical and therapeutic aspects of Bothrops asper bites, Toxicon, 54, 998, 10.1016/j.toxicon.2009.07.001 · DOI · Paper page
  48. Mora Rodríguez, 2008, Effects of Bothrops asper snake venom on lymphatic vessels: insights into a hidden aspect of envenomation, PLoS Neglected Trop Dis, 2, e318, 10.1371/journal.pntd.0000318 · DOI · Paper page
  49. Yamashita, 2014, Bothrops jararaca venom metalloproteinases are essential for coagulopathy and increase plasma tissue factor levels during envenomation, PLoS Neglected Trop Dis, 8, 10.1371/journal.pntd.0002814 · DOI
  50. Tang, 2016, Venomics of Calloselasma rhodostoma, the Malayan pit viper: a complex toxin arsenal unraveled, J Proteomics, 148, 44, 10.1016/j.jprot.2016.07.006 · DOI
  51. Chen, 2019, Snake venom proteome and immuno-profiling of the hundred-pace viper, Deinagkistrodon acutus, in Taiwan, Acta Trop, 189, 137, 10.1016/j.actatropica.2018.09.017 · DOI
  52. Kraisawat, 2020, Duration after Malayan pit viper bite to detect coagulopathy in Songklanagarind hospital, J Health Sci Med Res, 38, 93
  53. Su, 2018, Clinical and laboratory features distinguishing between Deinagkistrodon acutus and Daboia siamensis envenomation, J Venom Anim Toxins Incl Trop Dis, 24, 43, 10.1186/s40409-018-0179-2 · doi:10.1186/s40409-018-0179-2
  54. Bustillo, 2015, Phospholipase A2 enhances the endothelial cell detachment effect of a snake venom metalloproteinase in the absence of catalysis, Chem Biol Interact, 240, 30, 10.1016/j.cbi.2015.08.002 · DOI · Paper page
  55. Bustillo, 2012, Synergism between baltergin metalloproteinase and Ba SPII RP4 PLA2 from Bothrops alternatus venom on skeletal muscle (C2C12) cells, Toxicon, 59, 338, 10.1016/j.toxicon.2011.11.007 · DOI
  56. Montecucco, 2008, Cellular pathology induced by snake venom phospholipase A2 myotoxins and neurotoxins: common aspects of their mechanisms of action, Cell Mol Life Sci, 65, 2897, 10.1007/s00018-008-8113-3 · DOI · Paper page
  57. Lomonte, 2011, Phospholipases A2 from viperidae snake venoms: how do they induce skeletal muscle damage?., Acta Chim Slov, 58, 647
  58. Lewin, 2018, Delayed LY333013 (oral) and LY315920 (intravenous) reverse severe neurotoxicity and rescue juvenile pigs from lethal doses of Micrurus fulvius (Eastern coral snake) venom, Toxins, 10, 479, 10.3390/toxins10110479 · DOI · Paper page

Cited by

See all 35

Metadata

Authors
Xie, C., Slagboom, J., Albulescu, L.-O., Somsen, G. W., Vonk, F. J., Casewell, N. R., & Kool, J.
Venue
Acta Pharmaceutica Sinica B
Publisher
Elsevier BV
Published
2020-10
Volume
10
Issue
10
Pages
1835-1845
ISSN
2211-3835
Cited by
35
References
1
Language
en
Licence
Funders
  • Medical Research Council (200517/Z/16/Z, CiC19017, MR/S00016X/1)
  • Royal Society
  • China Scholarship Council (201706250035)
  • Wellcome Trust

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Neutralising effects of small molecule toxin inhibitors on nanofractionated coagulopathic Crotalinae snake venoms. https://app.cochat.ai/papers/10.1016/j.apsb.2020.09.005
The paper
Xie, C., Slagboom, J., Albulescu, L.-O., Somsen, G. W., Vonk, F. J., Casewell, N. R., & Kool, J. (2020). Neutralising effects of small molecule toxin inhibitors on nanofractionated coagulopathic Crotalinae snake venoms. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2020.09.005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.